Cargando…
Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial Office of Gut and Liver
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761918/ https://www.ncbi.nlm.nih.gov/pubmed/34373365 http://dx.doi.org/10.5009/gnl210246 |
| _version_ | 1784633642805362688 |
|---|---|
| author | Park, Sang Hyoung Ye, Byong Duk Yang, Suk-Kyun |
| author_facet | Park, Sang Hyoung Ye, Byong Duk Yang, Suk-Kyun |
| author_sort | Park, Sang Hyoung |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8761918 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Editorial Office of Gut and Liver |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87619182022-01-25 Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis? Park, Sang Hyoung Ye, Byong Duk Yang, Suk-Kyun Gut Liver Letter to the Editor Editorial Office of Gut and Liver 2022-01-15 2021-08-11 /pmc/articles/PMC8761918/ /pubmed/34373365 http://dx.doi.org/10.5009/gnl210246 Text en Copyright © Gut and Liver. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Park, Sang Hyoung Ye, Byong Duk Yang, Suk-Kyun Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis? |
| title | Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis? |
| title_full | Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis? |
| title_fullStr | Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis? |
| title_full_unstemmed | Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis? |
| title_short | Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis? |
| title_sort | infliximab versus adalimumab: can we choose the right one for the right patients with ulcerative colitis? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761918/ https://www.ncbi.nlm.nih.gov/pubmed/34373365 http://dx.doi.org/10.5009/gnl210246 |
| work_keys_str_mv | AT parksanghyoung infliximabversusadalimumabcanwechoosetherightonefortherightpatientswithulcerativecolitis AT yebyongduk infliximabversusadalimumabcanwechoosetherightonefortherightpatientswithulcerativecolitis AT yangsukkyun infliximabversusadalimumabcanwechoosetherightonefortherightpatientswithulcerativecolitis |